Recent advances in atypical parkinsonian disorders.
Recent advances in epidemiologic, diagnostic, pathologic, and management aspects of atypical parkinsonian disorders are reviewed and placed in perspective. The implications of considering progressive supranuclear palsy and corticobasal degeneration as tauopathies, and multiple system atrophy and dementia with Lewy bodies as alpha-synucleopathies are discussed.
Litvan
I
I
Neuropharmacology Unit, Defense and Veterans Head Injury Program, and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. litvan1@helix.nih.gov
D001921:Brain / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology